Viswa Colluru
CEO
Enveda Biosciences
Enveda Biosciences utilizes a platform that rapidly purifies, identifies, and characterizes natural molecules to accelerate drug discovery from plant sources. By unlocking the chemical potential of the vast majority of the natural world, Enveda aims to develop new medicines four times faster than traditional methods.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$360MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
The vast majority of natural compounds remain unexplored for drug discovery due to the time and cost associated with purifying, identifying, and characterizing individual molecules from complex natural mixtures. Traditional methods are slow and limit access to the chemical diversity present in the natural world.
Solution
Enveda Biosciences has developed a platform to rapidly purify, identify, and characterize natural molecules, accelerating drug discovery from plant sources. This platform unlocks the chemical potential of the natural world, enabling the development of new medicines faster than traditional methods. By leveraging advanced technologies, Enveda aims to translate nature's hidden chemistry into novel therapeutic candidates. The platform allows scientists to access and utilize the untapped potential of natural compounds for drug development.
Target Audience
The primary target audience includes pharmaceutical companies, research institutions, and drug discovery scientists seeking to accelerate the identification and development of novel therapeutics from natural sources.
Features
- High-throughput purification of individual molecules from complex natural mixtures
- Rapid identification of molecular structures
- Characterization of molecular activity
- Scalable platform for processing large volumes of natural samples